Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1158223/000144530514001231/affy1231201310-k.htm
September 2014
July 2014
June 2014
June 2014
May 2014
August 2013
August 2013
June 2013
May 2013
May 2013
Document and Entity Information (USD $) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2013 | Feb. 28, 2014 | Jun. 30, 2013 | |
Entity Information [Line Items] | |||
Entity Registrant Name | AFFYMAX INC | ||
Entity Central Index Key | 0001158223 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2013 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Public Float | $ 463,771,551 | ||
Entity Common Stock, Shares Outstanding | 37,490,095 | ||
Document Fiscal Year Focus | 2013 | ||
Document Fiscal Period Focus | FY |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1158223/000144530514001231/affy1231201310-k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Affymax Inc.
Affymax Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Affymax Inc provided additional information to their SEC Filing as exhibits
Ticker: AFFY
CIK: 1158223
Form Type: 10-K Annual Report
Accession Number: 0001445305-14-001231
Submitted to the SEC: Mon Mar 31 2014 4:44:08 PM EST
Accepted by the SEC: Mon Mar 31 2014
Period: Tuesday, December 31, 2013
Industry: Pharmaceutical Preparations